{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T21:14:22Z","timestamp":1698009262034},"reference-count":43,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":9563,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1987,1]]},"abstract":"<jats:p>Enalapril maleate (MK\u2010421) is a new non\u2010sulfhydryl\u2010containing converting\u2010enzyme inhibitor that has been shown to be effective and well tolerated in patients with essential hypertension. Data on its effectiveness and safety in patients with renovascular hypertension are limited and have involved predominantly short\u2010term observations. This is particularly true with respect to the long\u2010term effects of enalapril on renal function. We report our experience using the combination of enalapril and hydrochlorothiazide (HCTZ) in a group of nine patients with moderate to severe hypertension associated with renal artery stenosis. The enalapril\u2010HCTZ combination successfully controlled blood pressure in seven patients during a six\u2010week period of study. Adverse effects were not noted, and detailed renal hemodynamic studies did not reveal any significant changes of renal plasma flow and glomerular filtration rate during this time interval. Five patients were continued on this regimen for a period of six to 18 months. In this group of patients, the regimen continued to be well tolerated and to provide excellent blood pressure control: glomerular filtration rate was maintained in two patients and variable grades of decrease were noted in three. The mechanism of this delayed renal dysfunction as well as its relationship to enalapril treatment remain unclear. The long\u2010term impact of converting\u2010enzyme inhibition on renal function requires further study.<\/jats:p>","DOI":"10.1177\/009127008702700105","type":"journal-article","created":{"date-parts":[[2007,6,22]],"date-time":"2007-06-22T00:52:18Z","timestamp":1182473538000},"page":"32-40","source":"Crossref","is-referenced-by-count":4,"title":["Enalapril in the Management of Hypertension Associated With Renal Artery Stenosis"],"prefix":"10.1002","volume":"27","author":[{"given":"Vincent J.","family":"Canzonello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Madaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolaos E.","family":"Madias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"425","volume-title":"Management of Essential Hypertension.","author":"McMahon FG","year":"1984"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/archinte.1984.04400010055010","article-title":"Low\u2010dose Captopril for treatment of mild to moderate hypertension","volume":"144","author":"Veterans Administration Cooperative Study Group on Antihypertensive Agents.","year":"1984","journal-title":"Arch Intern Med"},{"issue":"3","key":"e_1_2_1_4_2","first-page":"108","article-title":"Monotherapy of essential hypertension with a converting\u2010enzyme inhibitor","volume":"5","author":"Drayer JIM","year":"1983","journal-title":"Hypertension"},{"key":"e_1_2_1_5_2","first-page":"852","article-title":"Medical therapy of renovascular hypertension: Efficacy and safety of Captopril in 269 patients","volume":"4","author":"Hollenberg NK","year":"1983","journal-title":"Cardiovasc Rev Rep"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1983.101"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1983.198"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(84)80054-6"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.6.2.167"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(84)80027-X"},{"key":"e_1_2_1_11_2","first-page":"441","volume-title":"Management of Essential Hypertension.","author":"McMahon FG","year":"1984"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.285.6356.1697"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/00365599.1984.11783725","article-title":"Enalapril and lisinopril in renovascular hypertension\u2014antihypertensive and hormonal effects of two new angiotensin\u2010converting\u2010enzyme (ACE) inhibitors","volume":"79","author":"Kalberg BE","year":"1984","journal-title":"Scand J Urol Nephrol (Suppl)"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(84)80058-3"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90075-0"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(84)80055-8"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)90975-4"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1972.34"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0039-128X(76)90004-0"},{"key":"e_1_2_1_20_2","volume-title":"Renal Function Tests: Clinical Laboratory Procedures and Diagnosis.","author":"Liedtke RR","year":"1980"},{"key":"e_1_2_1_21_2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0094-0143(21)00206-8","article-title":"Advances in the medical management of renovascular hypertension","volume":"11","author":"Vidt DG","year":"1984","journal-title":"Urol Clin North Am"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00548761"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1984.tb02787.x"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(84)80057-1"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(84)90692-1"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(84)90882-9"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1979.19"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.53.5.592"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198410253111702"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-102-3-308"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.288.6421.886"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198302173080706"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198302173080707"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1983.00350060184031"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00253518"},{"key":"e_1_2_1_36_2","first-page":"860","article-title":"Initial dose of enalapril maleate (MK\u2010421) in renovascular hypertension","volume":"35","author":"Nagai R","year":"1984","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.6.2_Pt_2.I193"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-2-222"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92149-4"},{"key":"e_1_2_1_40_2","first-page":"1357","volume-title":"Diseases of the Kidney.","author":"Hunt JC","year":"1979"},{"key":"e_1_2_1_41_2","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1001\/archinte.1974.00320180106009","article-title":"Renal and renovascular hypertension: A reasoned approach to diagnosis and management","volume":"133","author":"Hunt JC","year":"1974","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)31321-9"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-0143(21)00203-2"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1983.72"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1177%2F009127008702700105","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1177\/009127008702700105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T23:09:39Z","timestamp":1697929779000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1177\/009127008702700105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1987,1]]}},"alternative-id":["10.1177\/009127008702700105"],"URL":"https:\/\/doi.org\/10.1177\/009127008702700105","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,1]]}}}